Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol vs Indacaterol + Tiotropium in Asthma
NCT02039011Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Feb 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tiotropium in asthma (2 arms), sponsored by University of Dundee. Primary endpoint: Provocation Dose of Mannitol causing 15% drop in FEV1. Started Feb 2014; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02039011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039011.